• Somatization is associated with altered serum levels of vitamin D, serotonin, and brain-derived neurotrophic factor in patients with predominant diarrhea irritable bowel syndrome

• Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial

• Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients

• Factors influencing rectal hypersensitivity in irritable bowel syndrome: A systematic review and meta-analysis

• Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study

• Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP)

• Working with Trauma in the Gastroenterology Setting

• Management of Sleep and Fatigue in Gastrointestinal Patients

• Practical Approaches to Working with a Gastrointestinal Psychologist

• Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

• Innovative approaches to service integration addressing the unmet needs of irritable bowel syndrome patients and new approaches for the needs of IBS patients

• Non-pharmacological strategies to treat irritable bowel syndrome: 2022 updatev

• Patients with Functional Somatic Syndromes--Fibromyalgia, Irritable Bowel Syndrome, Chronic Headaches, and Chronic Low Back Pain--Have Lower Outcomes And Higher Opioid Usage And Cost After Shoulder And Elbow Surgery

• The role of mind body interventions in the treatment of irritable bowel syndrome and fibromyalgia

• Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial

• Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice

• Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome

• Post COVID-19 irritable bowel syndrome

• Symptom management needs of patients with irritable bowel syndrome and concurrent anxiety and/or depression: A qualitative study

• Updates in functional dyspepsia and bloating

• Symptoms and health experience in irritable bowel syndrome with focus on men

• Circulating Polyunsaturated Fatty Acids and Pain Intensity in Five Chronic Pain Conditions

• Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute

• Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

• Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome

• Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea

• The low-FODMAP diet and the gluten-free diet in the management of functional abdominal bloating and distension

• Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience

• The serotonin receptor 3E variant is a risk factor for female IBS-D

• Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome

• Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes

• How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?

• Psychosocial and Sensory Factors Contribute to Self-Reported Pain and Quality of Life in Young Adults with Irritable Bowel Syndrome

• The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist

• Epidemiology of irritable bowel syndrome in hospitalized patients with inflammatory bowel disease: Nationwide Inpatient Sample analysis from 2007-2016

• Constipation in Children and Adolescents

• Modest Conformity Between Self-Reporting of Bristol Stool Form and Fecal Consistency Measured by Stool Water Content in Irritable Bowel Syndrome and a FODMAP and Gluten Trial

• Future of Brain-Gut Behavior Therapies: Mediators and Moderators

• Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and Anxiety

• Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials

• Bile Acid and Gut Microbiota in Irritable Bowel Syndrome

• Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet

• Association between Endometriosis, Irritable Bowel Syndrome and Eating Disorders: ENDONUT Pilot Study

• Diet and irritable bowel syndrome: an update from a UK consensus meeting

• Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction

• High-dimensional clustering of 4000 Irritable Bowel Syndrome Patients reveals Seven Distinct Disease Subsets

• Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

• Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial

• Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome

• Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies

• Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome

• Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management

• Like clockwork? (Re)imagining rhythms and routines when living with irritable bowel syndrome (IBS)

• Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling

• Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study

• Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome

• Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na +/H + Exchanger Isoform 3

• The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial

• Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome

• Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial

• Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS

• Extraintestinal manifestations in irritable bowel syndrome: A systematic review

• Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education

• Virtual Tai Chi program for patients with irritable bowel syndrome with constipation: Proof-of-concept feasibility trial

• Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

• Proposal for innovative and integrated approaches to the unmet needs of irritable bowel syndrome patients. Preliminary Vigour report

• AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation

• Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT

• Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

• Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions

• A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers

• Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome

• Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses

• A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer's disease and gastrointestinal tract disorders

• Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living

• Irritable bowel syndrome: Factors of importance for disease-specific quality of life

• Comparing probiotic and drug interventions in irritable bowel syndrome: a meta-analysis of randomised controlled trials

• Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?

• Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study

• AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

• Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT)

• Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome

• Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome

• Irritable bowel syndrome with food-related symptoms: Future directions in the clinical management

• Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

• Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia

• Lower Gastrointestinal Tract Disorders: Clinical Updates in Women's Health Care Primary and Preventive Care Review

• Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols

• Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support

• Physical activity for treatment of irritable bowel syndrome

• Sex-specific brain microstructural reorganization in irritable bowel syndrome

• Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study

• The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation

• Organizing and Developing a GI Motility Lab in Community Practice: Challenges and Rewards

• Functional bowel symptoms in the general population (Review)

• Mechanisms Underlying Food-Triggered Symptoms in Disorders of Gut-Brain Interactions

• A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels

• Diagnostic and therapeutic approach to persistent abdominal pain beyond irritable bowel syndrome

• Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome

• Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis

• The lived experience of irritable bowel syndrome: A focus on dietary management

• Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis

• Ratio of Omega-6/Omega-3 Polyunsaturated Fatty Acids Associated With Somatic and Depressive Symptoms in People With Painful Temporomandibular Disorder and Irritable Bowel Syndrome

• Female Pelvic Conditions: Chronic Pelvic Pain

• Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom

• The 'medically unexplained symptoms' syndrome concept and the cognitive-behavioural treatment model

• Cognitive Behavioral Therapy-Based Comprehensive Self-Management Program Improves Presenteeism in Persons with Irritable Bowel Syndrome: A Secondary Data Analysis

• Human intestinal spirochetosis, irritable bowel syndrome, and colonic polyps: A systematic review and meta-analysis

• An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

• A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study

• Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions

• The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis

• Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis

• Emotional stress responsivity of patients with IBS - a systematic review

• A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial

• Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndrome

• Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome

• Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study

• Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D

• Creation of a Multispecialty Clinic for Patients with Central Sensitization-Based Chronic Pain Conditions

• Review article: the effectiveness of group and self-help hypnotherapy for irritable bowel syndrome and the implications for improving patients' choice and access to treatment

• The Gut-Brain Axis

• Diagnoses of Exclusion in the Workup of Abdominal Complaints

• Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement

• Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome

• Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey

• Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression

• Communication between the gut microbiota and peripheral nervous system in health and chronic disease

• Immune responses in the irritable bowel syndromes: time to consider the small intestine

• Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study

• Are They Side Effects? Extra-intestinal Symptoms Reported During Clinical Trials of IBS May Be More Severe at Baseline

• AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review

• The association between gastro-oesophageal reflux and migraine in the paediatric population: a multicentre case-control study

• Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study

• Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions

• Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation

• Overlap of heartburn, functional dyspepsia, and irritable bowel syndrome in a population sample: Prevalence, temporal stability, and associated comorbidities

• Long-term personalized low FODMAP diet in IBS

• Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations

• A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form

• Review article: the patients' experience with irritable bowel syndrome and their search for education and support

• Review article: Diagnosis and investigation of irritable bowel syndrome

• Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M)

• Meta-analysis and systematic review of the association between adverse childhood events and irritable bowel syndrome

• The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic

• Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions

• Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis

• Clinical trials of probiotics in patients with IBS - some points to consider

• Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome

• Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study

• TEGASEROD: WHAT'S OLD IS NEW AGAIN

• Development and validation of a novel scoring system for bloating and distension: The Mayo Bloating Questionnaire

• QUALITATIVE VALIDATION OF A NOVEL VIRTUAL REALITY (VR) PROGRAM FOR IRRITABLE BOWEL SYNDROME: A VR1 STUDY

• Critical Connections Among Embedding of Childhood Adversity and Adult Chronic Gastrointestinal and Genitourinary Disorders: A Review of the Literature

• The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials

• Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders

• Irritable bowel syndrome and diet

• Irritable bowel syndrome and long-term risk of cancer: a prospective cohort study among 0.5 million adults in UK Biobank

• Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany

• The changes in prevalence and risk of irritable bowel syndrome over time in a population-based cohort, the HUNT study, Norway

• Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold

• Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis

• Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome

• Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome

• Biopsychosocial Model and Perceived Constipation Severity According to the Constipation Phenotype

• A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome

• Subtypes and Severity of Irritable Bowel Syndrome Are Not Related to Patients' Self-Reported Dietary Triggers: Results From an Online Survey in Dutch Adults

• Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria

• A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome

• Chronic Diseases, Health Conditions, and Other Impacts Associated With Rape Victimization of U.S. Women

• Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial

• Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post-surgical patients

• Association between Brachyspira and irritable bowel syndrome with diarrhoea

• Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome

• Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

• Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis

• The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population

• Microbiome and paediatric gut diseases

• Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG

• Diagnostic yield of endoscopy in irritable bowel syndrome: A nationwide prevalence study 1987-2016

• Associations of Abdominal Pain and Psychosocial Distress Measures With Health-Related Quality-of-Life in Pediatric Healthy Controls and Irritable Bowel Syndrome

• Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

• Diet Interventions for Irritable Bowel Syndrome: Separating the Wheat from the Chafe

• Making a Confident Diagnosis of Irritable Bowel Syndrome

• Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial

• Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief

• Development of a Score to Predict Positive Colonic Histology in Chronic Diarrhea Assessed in Open-access Colonoscopy

• Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

• Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis

• Making a Confident Diagnosis of Irritable Bowel Syndrome

• Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial

• Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief

• Diet Interventions for Irritable Bowel Syndrome: Separating the Wheat from the Chafe

• Making a Confident Diagnosis of Irritable Bowel Syndrome

• The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea

• Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey

• Sensory Adaptation Training or Escitalopram for IBS With Constipation and Rectal Hypersensitivity: A Randomized Controlled Trial

• Latest Insights on the Pathogenesis of Irritable Bowel Syndrome

• Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome

• Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective

• AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut-Brain Interaction: Expert Review

• FODMAP Consumption by Adults from the French Population-Based NutriNet-Santé Cohort

• The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome

• Irritable bowel syndrome and migraine: evidence from Mendelian randomization analysis in the UK Biobank

• Predictors of aetiology and outcomes of acute gastrointestinal illness in returning travellers: a retrospective cohort analysis

• A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome

• COVID-19 pandemic and lockdown stress consequences in people with and without Irritable Bowel Syndrome

• Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis

• Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome

• Irritable Bowel Syndrome: Questions and Answers for Effective Care

• Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation

• Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study

• Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study

• Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test

• Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity

• The Role of Epigenomic Regulatory Pathways in the Gut-Brain Axis and Visceral Hyperalgesia

• Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients with Irritable Bowel Syndrome

• Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies

• Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options

• The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study

• Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis

• Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome

• Probiotics and gut health

• Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials

• Reevaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data

• Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis

• Shiftwork, functional bowel symptoms, and the microbiome

• Usability Evaluation of a Smartphone Medication Reminder Application in Patients Treated With Short-term Antibiotic

• Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

• Cognitive and emotional variables predicting treatment outcome of cognitive behavior therapies for patients with medically unexplained symptoms: A meta-analysis

• The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases

• The Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-Management of Irritable Bowel Syndrome: a Cross-Over, Randomized Controlled Trial

• Different Dimensions of Affective Processing in Patients With Irritable Bowel Syndrome: A Multi-Center Cross-Sectional Study

• Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach

• Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia

• Associations between dairy consumption and constipation in adults: A cross-sectional study

• Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome

• Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome

• Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome

• Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome

• Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-up Study

• Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome

• Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression

• Minimal-Contact Versus Standard Cognitive Behavioral Therapy for with Irritable Bowel Syndrome: Cost-Effectiveness Results of a Multisite Trial

• Written expressive disclosure in adults with irritable bowel syndrome: A randomized controlled trial

• Pregnancy, delivery, and neonatal outcomes among women with irritable bowel syndrome (IBS) an evaluation of over 9 million deliveries

• Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide

• Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome

• Interactional practices in person-centred care: Conversation analysis of nurse-patient disagreement during self-management support

• Bugs and Brains, the Gut and Mental Health Study: a mixed-methods study investigating microbiota composition and function in anxiety, depression and irritable bowel syndrome

• The association between ectopic pregnancy and inflammatory bowel disease, irritable bowel syndrome, and celiac disease: A systematic review

• A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome

• Up-to-Date Diagnosis and Management of IBS and Chronic Constipation in Primary Care

• The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis

• Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

• Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value

• The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection

• When Eating Becomes a Pain in the Gut

• Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D

• Diagnosis and Treatment of Irritable Bowel Syndrome: A Review

• Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial

• Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components

• Irritable bowel syndrome and Parkinson's disease risk: register-based studies

• A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial

• The gut virome in Irritable Bowel Syndrome differs from that of controls

• Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome

• Dietary Patterns in Runners with Gastrointestinal Disorders

• Impact of Diet on Symptoms of the Irritable Bowel Syndrome

• Management of irritable bowel syndrome with diarrhea: focus on eluxadoline

• The Microbiota-Gut-Brain Axis: From Motility to Mood

• Factors that contribute to the impairment of quality of life in gastroparesis

• Targeted pharmacotherapy of irritable bowel syndrome

• Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults

• A systematic review of the association between fibromyalgia and functional gastrointestinal disorders

• An Intervention With Dance and Yoga for Girls With Functional Abdominal Pain Disorders (Just in TIME): Protocol for a Randomized Controlled Trial

• ACG Clinical Guideline: Management of Irritable Bowel Syndrome

• Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

• Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence

• Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track

• Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial

• Practitioners

• Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update

• Inflammatory Bowel Disease and Irritable Bowel Syndrome

• Patients

• A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles

• Therapy of IBS: Is a Low FODMAP Diet the Answer?

• Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update

• An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome

• Irritable bowel syndrome

• Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

• Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome

• Functional gastrointestinal disorders: advances in understanding and management

• The patient with irritable bowel syndrome-type symptoms: when to investigate and how?

• A positive diagnostic strategy is safe and saves endoscopies in patients with irritable bowel syndrome: A five-year follow-up of a randomized controlled trial

• Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis

• Comparing costs and outcomes of treatments for irritable bowel syndrome with diarrhea: cost-benefit analysis

• Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis

• Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry

• Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT)

• Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome

• Dilemma in post-IBD patients with IBS-D symptoms; A 2020 overview

• Parental, Perinatal, and Childhood Risk Factors for Development of Irritable Bowel Syndrome: A Systematic Review

• Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

• ACTIVATION OF THE INNATE IMMUNE SYSTEM IN CHILDREN WITH IRRITABLE BOWEL SYNDROME EVIDENCED BY INCREASED FECAL HUMAN ß-DEFENSIN-2

• Potential Benefit with Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

• CSP01, a Novel Superabsorbent Hydrogel, Reduces Colonic Transit Time in Patients With Chronic Idiopathic Constipation in a Randomized, Doubleblind, Controlled Pilot Clinical Trial

• Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome

• Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review

• Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice

• More than consent for ethical open-label placebo research

• Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach

• The role of resilience in irritable bowel syndrome, other chronic gastrointestinal conditions and the general population

• Feasibility, acceptability and cost efficiency of using webinars to deliver first-line patient education for people with Irritable Bowel Syndrome as part of a dietetic-led gastroenterology service in primary care

• Complementary and Alternative Medicine Use in Pediatric Functional Abdominal Pain Disorders at a Large Academic Center

• Irritable Bowel Syndrome: Straightening the road from the Rome criteria

• Management of Irritable Bowel Syndrome: Physician-Dietitian Collaboration

• A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up

• Understanding the Psychosocial and Parenting Needs of Mothers with Irritable Bowel Syndrome with Young Children

• Cannabis and the Gastrointestinal Tract

• Irritable bowel syndrome with diarrhea: Treatment is a work in progress

• Food supplements and diet as treatment options in irritable bowel syndrome

• The association between low birth weight, childhood recollections of parental response to illness, and irritable bowel syndrome: a twin study

• Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: The Chronic Constipation and IBS-C Treatment and Outcomes Real-world Research Platform (CONTOR)

• AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review

• Cytokine Levels and Symptoms Among Women With Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive use

• Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers

• Review Article: FODMAPS, Prebiotics and Gut Health-The FODMAP Hypothesis Revisited

• Predictors of New Onsets of Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Fibromyalgia: The Lifelines Study

• Associations of Abdominal Pain and Psychosocial Distress Measures With Health-Related Quality-of-Life in Pediatric Healthy Controls and Irritable Bowel Syndrome

• Skills Over Pills? A Clinical Gastroenterologist's Primer in Cognitive Behavioral Therapy for Irritable Bowel Syndrome

• Postmenopausal Women With Irritable Bowel Syndrome (IBS) Have More Severe Symptoms Than Premenopausal Women With IBS

• Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation

• The Effects of Gastrointestinal Symptoms on Structural Gray Matter Volume in Youth

• Challenges of the Low FODMAP Diet for Managing Irritable Bowel Syndrome and Approaches to Their Minimisation and Mitigation

• Functional Gastrointestinal Disorders in Children: What Is New?

• ß-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria

• Application of Metabolomics to the Study of Irritable Bowel Syndrome

• The Effect of Sleep on Gastrointestinal Functioning in Common Digestive Diseases

• Twitter Debate: Controversies in Functional Gastrointestinal Disorders

• Randomised Clinical Trial: Linaclotide vs Placebo-A Study of Bi-Directional Gut and Brain Axis

• Clinical Accuracy of a New Rapid Assay for Fecal Calprotectin Measurement

• Efficacy of Psychological Therapies for Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis

• Heat-inactivated Bifidobacterium Bifidum MIMBb75 (SYN-HI-001) in the Treatment of Irritable Bowel Syndrome: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial

• Shared Decision Making in Gastroenterology: Challenges and Opportunities

• Tenapanor for Constipation-Predominant Irritable Bowel Syndrome

• Efficacy of Psychological Therapies for Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis

• Management of Chronic Abdominal Distension and Bloating

• Evidence-based and mechanistic insights into exclusion diets for IBS

• Overlap between Irritable Bowel Syndrome Diagnosis and Endometriosis in Adolescents

• Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data

• Distinct associations of DSM-5 Somatic Symptom Disorder, the Diagnostic Criteria for Psychosomatic Research-Revised (DCPR-R) and symptom severity in patients with irritable bowel syndrome

• Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study

• Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults

• Management of Chronic Abdominal Distension and Bloating

• Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome

• Rational investigations in irritable bowel syndrome

• A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome-Effects and mechanisms

• Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study

• Low FODMAP Diet: Evidence, Doubts, and Hopes

• Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn

• Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy

• Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis

• The Potential of Integrated Nurse-Led Models to Improve Care for People With Functional Gastrointestinal Disorders: A Systematic Review

• Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials

• Plecanatide for the treatment of constipation-predominant irritable bowel syndrome

• Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom

• Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms

• Relationships Between Abdominal Pain and Fatigue With Psychological Distress as a Mediator in Women With Irritable Bowel Syndrome

• Understanding the Scope of Do-It-Yourself Fecal Microbiota Transplant.

• Gut permeability is affected by sex and increased in children with irritable bowel syndrome but not in functional abdominal pain

• Patient dissatisfaction with medical therapy for chronic constipation or irritable bowel syndrome with constipation: analysis of N-of-1 prospective trials in 81 patients

• Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome

• Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review

• Does a Minority of Children With Functional Gastrointestinal Disorders Receive Formal Diet Advice?

• Microbiome and Its Role in Irritable Bowel Syndrome

• Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation

• Sex as a biological variable in irritable bowel syndrome

• Stigma and irritable bowel syndrome: a taboo subject?

• Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)

• Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel SyndromeSubtype: Results of a Nationwide Population-Based Study

• Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

• Irritable bowel syndrome and gut microbiota

• What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model

• Irritable bowel syndrome and gut microbiota

• Yoga as a Therapy for Irritable Bowel Syndrome

• Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis

• The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial

• Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

• Relationship between adverse childhood experiences and illness anxiety in irritable bowel syndrome - The impact of gender

• Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

• Diagnosis and management of renal dysfunction in patients with cirrhosis

• Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis

• Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary

• Immune Activation in Functional Gastrointestinal Disorders

• The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review

• Impact of eHealth technologies on patient outcomes: a meta-analysis of chronic gastrointestinal illness interventions

• Pathophysiology of the irritable bowel syndrome - Reflections of today

• The Alignment of Dietary Intake and Symptom-Reporting Capture Periods in Studies Assessing Associations between Food and Functional Gastrointestinal Disorder Symptoms: A Systematic Review

• The Gluten-Free Diet: Use in Digestive Disease Management

• Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

• Biofeedback for treatment of irritable bowel syndrome

• Postinfectious Irritable Bowel Syndrome After Campylobacter Infection

• Chronic constipation: new insights, better outcomes?

• Tegaserod for the Treatment of Irritable Bowel Syndrome

• Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome

• Stressful Life Events Moderate the Relationship Between Changes in Symptom Severity and Health-related Quality of Life in Patients With Irritable Bowel Syndrome

• Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

• Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder

• Nursing management of irritable bowel syndrome

• Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey

• Adherence to Short-course Pharmacotherapy in Adults with Irritable Bowel Syndrome

• Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial

• Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review

• Relations between food intake, psychological distress, and gastrointestinal symptoms: A diary study

• The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study

• Chronic Diarrhea Evaluation in the Elderly: IBS or Something Else?

• Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome

• How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study

• Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

• AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)

• Effects of Psychology and Extragastrointestinal Symptoms on Health Care Use by Subjects With and Without Irritable Bowel Syndrome

• Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction

• Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

• The role of mast cells in pediatric gastrointestinal disease

• Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction

• How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study

• Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome With Constipation

• Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies

• Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron

• Gut Microbiome: Profound Implications for Diet and Disease

• Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea

• Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey

• A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients

• Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation

• An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction

• How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study

• Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients

• Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome

• AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

• Treatment failure in children diagnosed with constipation in a paediatric emergency department in relation to Rome III criteria

• Information Literacy in Food and Activity Tracking Among Parkrunners, People With Type 2 Diabetes, and People With Irritable Bowel Syndrome: Exploratory Study

• The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study

• Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

• Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome

• Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D

• The good bugs: the use of probiotics in pediatrics

• Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow

• Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

• Chronic Diarrhea Evaluation in the Elderly: IBS or Something Else?

• Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies

• Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation

• The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome

• Gut Microbiome: Profound Implications for Diet and Disease

• Identifying and Planning for Individualized Change: Patient-Provider Collaboration Using Lightweight Food Diaries in Healthy Eating and Irritable Bowel Syndrome

• Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)

• Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS

• Gender-based Differences among 1990-1991 Gulf War Era Veterans: Demographics, Lifestyle Behaviors, and Health Conditions

• Irritable bowel syndrome: a new therapeutic target when treating obesity?

• Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer

• Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria

• Role of brain imaging in disorders of brain-gut interaction: a Rome Working Team Report

• The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea

• Increased Gut Permeability in First-degree Relatives of Children with Irritable Bowel Syndrome or Functional Abdominal Pain

• Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E

• Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome

• Irritable Bowel Syndrome is Underdiagnosed and Ineffectively Managed Among Endurance Athletes

• Update on Pharmacotherapy for Irritable Bowel Syndrome

• Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?

• Noninvasive Diagnosis of Irritable Bowel Syndrome via Bowel Sound Features: Proof of Concept

• Should We Use Tegaserod for Irritable Bowel Syndrome?

• The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study

• Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

• Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

• Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy

• Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease

• Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials

• Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome

• Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome

• Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome

• Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis

• Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review

• Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan

• Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course

• Primary healthcare utilisation and self-rated health among patients with Irritable Bowel Syndrome: What are the impacts of comorbidities, gastrointestinal symptom burden, sense of coherence and stress?

• Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?

• Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review

• Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents

• Gut Microbiota in Patients With Irritable Bowel Syndrome-a Systematic Review

• Irritable Bowel Syndrome and Dietary Interventions

• Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy

• Prucalopride for the treatment of constipation: a view from 2015 and beyond

• Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia

• Integrating psychosocial approaches into the management of childhood functional gastrointestinal disorders: a role for social work

• Altered Brain Structure and Functional Connectivity and Its Relation to Pain Perception in Girls With Irritable Bowel Syndrome

• SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment

• Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey

• Efficacy of the gluten free diet in the management of functional gastrointestinal disorders: a systematic review on behalf of the Italian Society of Paediatrics

• Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome

• Nonpharmacologic options for treating irritable bowel syndrome

• Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome

• The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity

• Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

• Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment

• Conditioned Pain Modulation (CPM) is Reduced in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of CPM and the Role of Psychological Factors

• Overlapping irritable bowel syndrome and inflammatory bowel disease

• Elimination Diets for Irritable Bowel Syndrome: Approaching the End of the Beginning

• Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

• The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data

• Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

• Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study

• Negative Events During Adulthood are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome

• Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms

• Fibromyalgia and Irritable Bowel Syndrome in Female Pelvic Pain

• Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome

• Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome

• Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome

• Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders

• Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial

• Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome

• Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities

• Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research

• Montezuma's revenge - the sequel: The one-hundred year anniversary of the first description of "post-infectious" irritable bowel syndrome

• Probiotics in irritable bowel syndrome: Where are we?

• Irritable Bowel Syndrome: What Treatments Really Work

• Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review

• Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up

• Pediatric Integrative Medicine in Academia: Stanford Children's Experience

• A review of the gluten-free diet in non-celiac patients: beliefs, truths, advantages and disadvantages

• Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome

• Management Options for Irritable Bowel Syndrome

• Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?

• Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review

• Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors

• Update on Dietary Management of Childhood Functional Abdominal Pain Disorders

• Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials

• Gluten-Free Diet and Its 'Cousins' in Irritable Bowel Syndrome

• Association of Fatigue With TPH2 Genetic Polymorphisms in Women With Irritable Bowel Syndrome

• UK clinical experience up to 52?weeks with linaclotide for irritable bowel syndrome with constipation

• Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome

• Symptomatology Correlations Between the Diaphragm and Irritable Bowel Syndrome

• A Protocol-Driven Assessment Promotes a More Accurate Diagnosis of Irritable Bowel Syndrome

• Changing Beliefs About Emotions in IBS: A Single Case Design

• Irritable bowel syndrome following Clostridium difficile infection

• Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study

• Probiotics in Disease Prevention and Treatment

• Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome

• Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review

• The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children

• Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

• Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center

• Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation.

• Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation

• Influence of Dietary Restriction on Irritable Bowel Syndrome

• Naturopathic Approaches to Irritable Bowel Syndrome-A Delphi Study

• Fecal microbiota transfer for bowel disorders: efficacy or hype?

• Clinical application of dietary therapies in irritable bowel syndrome

• Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

• Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study

• Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

• Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey

• Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome

• The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea

• Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a United States National survey

• A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults

• Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable

• Reduced Symptoms of Post-traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans

• Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis

• Pre- and probiotic overview

• Review article: an analysis of safety profiles of the treatments for diarrhoea-predominant irritable bowel syndrome

• Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

• Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports

• Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease

• Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic

• Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome

• Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome

• A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome

• Association between 2 painful and poorly understood conditions: irritable bowel and sensitive skin syndromes

• The gut microbiome and irritable bowel syndrome

• Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists

• Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders

• Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics

• Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease

• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs

• Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome

• Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians

• Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome

• Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study

• Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

• Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

• A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study

• Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine

• Implications of Pharmacogenomics to the Management of IBS

• The "Biology-First" Hypothesis: Functional disorders may begin and end with biology-A scoping review

• Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

• Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States

• Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

• Use of Sourdough in Low FODMAP Baking

• No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease

• Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire

• Refractory Constipation: What is the Clinician to Do?

• Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome

• Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

• Implications of Pharmacogenomics to the Management of IBS

• Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study

• Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review

• Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome

• Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics

• The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs

• Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine

• Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

• Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

• Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update

• The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis

• Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review

• Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome

• Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study

• Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome

• Pediatric Irritable Bowel Syndrome: Perspectives on Pain and Adolescent Social Functioning

• No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease

• Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States

• Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments

• Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

• Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms

• Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome

• Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea

• Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study

• Health problems associated with irritable bowel syndrome: analysis of a primary care registry

• Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome

• Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview

• Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus

• Functional Bowel Disorders Gastroenterology's 75th anniversary

• Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials

• Functional Gastrointestinal Disorders: Functional Lower Gastrointestinal Disorders in Adults

• Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study

• Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals

• Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation

• Development of Irritable Bowel Syndrome Features Over a 5-year Period

• Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome

• The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review

• Gut Microbiota-Based Therapies for Irritable Bowel Syndrome

• Fermentable short chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for vegetarian- and vegan-based eating patterns

• Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV

• Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: an Acttion Systemic Review

• Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis

• The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review

• Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome

• Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome

• Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions

• Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution

• The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice

• Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study

• Layperson's knowledge and perceptions of irritable bowel syndrome as potential barriers to care

• Best uses of osteopathic manipulation

• Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome

• Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?

• The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome

• Evidence-based management of irritable bowel syndrome with diarrhea

• Wake-up Call to Clinicians: The Impact of Sleep Dysfunction on Gastrointestinal Health and Disease

• Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation

• Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide

• The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report

• Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research

• New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

• Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study

• The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome(IBS)

• Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education

• The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update

• Stress & the gut-brain axis: Regulation by the microbiome

• Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance

• Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

• Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?

• Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial

• Celiac disease is uncommon in irritable bowel syndrome in the USA

• An update on prucalopride in the treatment of chronic constipation

• Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis

• Medicinal Foods for Functional GI Disorders

• Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment

• Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome

• Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions

• Pharmacotherapy for Irritable Bowel Syndrome

• New therapies in Irritable Bowel Syndrome: what works and when

• Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome

• AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome

• The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study

• Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders

• Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome

• Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response

• General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study

• Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases

• Role of G protein-coupled receptors-microRNA interactions in Gastrointestinal Pathophysiology

• The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome

• Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients

• Complementary and Integrative Gastroenterology

• Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients

• Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial

• The global impact of IBS: time to think about IBS-specific models of care?

• Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes

• The place of eluxadoline in the management of irritable bowel syndrome with diarrhea

• Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article

• Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by ?-Galactosidase Treatment

• Irritable bowel syndrome and diet: where are we in 2018?

• Prokinetics in the Management of Functional Gastrointestinal Disorders

• Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease

• Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts

• Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender

• Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?

• A psychology of the human brain-gut-microbiome axis

• Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome with Eluxadoline

• Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome

• Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population

• Advances in IBS 2016: A Review of Current and Emerging Data

• A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset

• Rifamycins, Alone and in Combination

• Modern Management of Irritable Bowel Syndrome: More Than Motility

• British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)

• Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk

• Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment

• Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation

• Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness

• Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome

• Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomised controlled trial

• Gut microbiota role in irritable bowel syndrome: New therapeutic strategies

• Inflammation in irritable bowel syndrome: Myth or new treatment target?

• Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials

• Hot Topics in Primary Care: Individualizing Pharmacologic Management of Irritable Bowel Syndrome

• Is irritable bowel syndrome an infectious disease?

• Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome

• The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study

• Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders

• Rifaximin and Eluxadoline - Newly Approved Treatments for Diarrhea-Predominant Irritable Bowel Syndrome: What is Their Role in Clinical Practice Alongside Alosetron?

• Managing irritable bowel syndrome in primary care

• Probiotics in Irritable Bowel Syndrome: The Science and the Evidence

• New and Emerging Treatment Options for Irritable Bowel Syndrome

• Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion

• Irritable Bowel Syndrome and Microscopic Colitis: a Systematic Review and Meta-analysis

• Irritable bowel syndrome in patients with quiescent inflammatory bowel disease. A review

• Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the

• Gender differences in irritable bowel syndrome: the interpersonal connection

• Increased Risk of Functional Gastrointestinal Sequelae Following Clostridium difficile infection among Active Duty United States Military Personnel (1998-2010)

• A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms

• Diet low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial

• Diagnostic outcomes following childhood non-specific abdominal pain: a record-linkage study

• Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis

• RIFAXIMIN: THE REVOLUTIONARY ANTIBIOTIC APPROACH FOR IRRITABLE BOWEL SYNDROME

• Prokinetics in the Management of Functional Gastrointestinal Disorders

• Pharmacogenetics in irritable bowel syndrome

• Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity

• Drug discovery approaches to irritable bowel syndrome

• Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults

• Symbiotics in irritable bowel syndrome - better than probiotics alone?

• Disability in Children and Adolescents with Irritable Bowel Syndrome and/or Fibromyalgia

• A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS

• Irritable Bowel Syndrome: Modern Concepts and Management Options

• Irritable bowel syndrome: an integrated explanatory model for clinical practice

• Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome

• The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

• Irritable bowel syndrome: new and emerging treatments

• Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers

• Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina

• Is fructose malabsorption a cause of irritable bowel syndrome?

• Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina

• Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome

• Evidence Against Routine Testing of Patients with Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study

• Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents

• Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared to Healthy Controls

• Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome

• Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome

• New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics

• A systematic review of integrated traditional chinese and Western medicine for managing irritable bowel syndrome

• Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology

• Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea

• Obesity and irritable bowel syndrome: a comprehensive review

• Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea

• A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome

• Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

• Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009

• New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin

• The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden

• Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder

• Irritable bowel syndrome: a clinical review

• Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

• High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria

• Abdominal pain endpoints currently recommended by the FDA and EMA for adult patients with irritable bowel syndrome may not be reliable in children

• Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea

• Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

• Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease

• Irritable bowel syndrome: an integrated explanatory model for clinical practice

• A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS

• Irritable Bowel Syndrome: Modern Concepts and Management Options

• Lubiprostone in constipation: clinical evidence and place in therapy

• Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009

• A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome

• Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity

• The Science, Evidence and Practice of Dietary Interventions in Irritable Bowel Syndrome

• Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study

• The Effect of Emotional Stress and Depression on the Prevalence of Digestive Diseases

• Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study

• Stress and chronic pelvic pain

• Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder

• A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

• Risk for irritable bowel syndrome in fibromyalgia patients: a national database study

• Chronic multisymptom illness among female veterans deployed to iraq and afghanistan

• The rise and fall of gluten!

• Functional gastrointestinal disorders in 35 447 adults and their association with body mass index

• IBS-like symptoms in patients with ulcerative colitis

• Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

• Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review

• Rifaximin: irritable bowel syndrome

• Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases

• Genetic polymorphism in pathogenesis of irritable bowel syndrome

• Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report

• Perceived risk as a barrier to appropriate diagnosis of irritable bowel syndrome